Weight-Loss drug may fight uterine cancer in new trial
NCT ID NCT07078838
Summary
This study is testing if a medication called tirzepatide, which is used for weight loss and diabetes, can slow the growth of abnormal cells in the uterus before a patient's scheduled surgery. It will involve 40 women with obesity who have been diagnosed with a pre-cancerous condition or early-stage endometrial cancer. Researchers will compare tissue samples from women who receive the drug for four weeks before surgery to those who do not, to see if the drug reduces cancer cell growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.